Chronic wound care market seen reaching $26 billion by 2033

Persistence Market Research projects the global chronic wound care market will rise from $16.2 billion in 2026 to $26.0 billion by 2033, driven by diabetes, obesity and aging populations. Advanced wound dressings and hospital use are leading the market as North America holds the top regional share.

Why it matters: - Chronic wounds such as diabetic foot ulcers, pressure ulcers and venous leg ulcers drive long treatment cycles, higher infection risk and longer hospital stays. - Demand for advanced wound care products is rising as health systems look for better healing outcomes and lower complication rates. - The market outlook signals continued spending on wound management technologies across hospitals and home care.

What happened: - Persistence Market Research valued the global chronic wound care market at $16.2 billion in 2026 and projected it will reach $26.0 billion by 2033. - The report forecasts a 7.0% compound annual growth rate over the period. - The report identifies advanced wound dressings as the leading product category. - Hospitals remain the largest end-user segment. - North America leads the global market. - The report is available through a free sample report, with report customization and full report purchase also offered.

The details: - The market covers advanced wound dressings, traditional wound care products, wound therapy devices, biologics and other wound management solutions. - Advanced wound dressings lead because they maintain moisture, improve healing and reduce complications. - The report says hospitals dominate because they handle the highest number of chronic wound cases and have specialized wound care services. - Home healthcare is expanding as patients seek more convenient long-term care outside hospitals. - Key drivers include rising cases of diabetes, obesity and cardiovascular disease. - The report also points to continuous product innovation, better clinical outcomes and higher healthcare investment. - North America’s lead is tied to advanced healthcare infrastructure, strong reimbursement systems and broad adoption of innovative wound care technologies. - Europe shows stable demand. - Asia Pacific is emerging as a high-growth region because of expanding healthcare infrastructure, more diabetes cases and rising awareness of advanced wound management. - Key companies named in the market include Smith & Nephew, Mölnlycke Health Care, 3M, ConvaTec, Coloplast, Integra LifeSciences, Organogenesis, B. Braun, Medline, PAUL HARTMANN, Essity and Cardinal Health.

Between the lines: - The growth forecast reflects a broader shift toward higher-value wound therapies instead of basic dressings. - The restraint profile shows that adoption will not be uniform, especially where treatment costs, reimbursement gaps and delayed diagnosis remain barriers. - The opportunity set suggests regenerative medicine, biologics and smart wound care could become the next growth engines.

What's next: - The market is likely to keep expanding as chronic disease rates rise and hospitals and home-care providers widen access to advanced wound treatments. - Future growth may depend on whether manufacturers can lower costs and meet regulatory demands in more markets. - Emerging economies could contribute more to demand as healthcare access improves.